Table 1 Participant’s demographic and clinical characteristics (n = 607 patients)
Patients’ characteristics | n (%) | 95% CI |
|---|---|---|
Age, years | ||
 18 to 35 | 84 (13.84) | (11.31 to 16.83) |
 36 to 45 | 130 (21.42) | (18.33 to 24.87) |
 46 to 64 | 268 (44.15) | (40.24 to 48.14) |
  > 64 | 125 (20.59) | (17.56 to 24.00) |
Gender | ||
 Male | 275 (45.30) | (41.37 to 49.29) |
 Female | 332 (54.70) | (50.71 to 58.63) |
Marital status | ||
 Never married | 24 (3.95) | (2.66 to 5.84) |
 Married | 537 (88.47) | (85.67 to 90.78) |
 Widowed/divorced/separated | 46 (7.58) | (5.72 to 9.98) |
Education | ||
 No education | 286 (47.19) | (43.24 to 51.19) |
 Primary | 153 (25.25) | (21.94 to 28.87) |
 Secondary | 94 (15.51) | (12.84 to 18.62) |
 Higher secondary | 45 (7.43) | (5.59 to 9.81) |
 Tertiary | 28 (4.62) | (3.21 to 6.62) |
BMI group | ||
 Underweight: < 18.49 | 100 (16.47) | (13.73 to 19.65) |
 Healthy weight: 18.50 to 24.99 | 373 (61.45) | (57.5 to 65.25) |
 Overweight: 25.00 to 29.99 | 90 (14.83) | (12.21 to 17.89) |
 Obese: ≥ 30 | 44 (7.25) | (5.43 to 9.61) |
Residence | ||
 Rural | 534 (87.97) | (85.13 to 90.33) |
 Urban | 73 (12.03) | (9.67 to 14.87) |
Family members | ||
  < 4 | 76 (12.52) | (10.11 to 15.41) |
 4 to 5 | 298 (49.09) | (45.12 to 53.08) |
  ≥ 6 | 233 (38.39) | (34.59 to 42.33) |
Occupation | ||
 Unemployed | 140 (23.06) | (19.88 to 26.59) |
 Employed | 39 (6.43) | (4.73 to 8.68) |
 Businessperson | 41 (6.75) | (5.01 to 9.05) |
 Housewife | 248 (40.86) | (37 to 44.83) |
 Informal workers | 40 (6.59) | (4.87 to 8.87) |
 Students | 13 (2.14) | (1.25 to 3.66) |
 Other occupations | 86 (14.17) | (11.61 to 17.18) |
Income quintile | ||
 Q1 (20% lowest) | 208 (34.27) | (30.59 to 38.14) |
 Q2 | 53 (8.73) | (6.73 to 11.26) |
 Q3 | 111 (18.29) | (15.40 to 21.57) |
 Q4 | 130 (21.42) | (18.33 to 24.87) |
 Q5 (20% highest) | 105 (17.30) | (14.49 to 20.52) |
Received COVID-19 vaccine | ||
 No | 172 (28.34) | (24.89 to 32.06) |
 Yes | 435 (71.66) | (67.94 to 75.11) |
Smoking history | ||
 No | 446 (73.48) | (69.81 to 76.84) |
 Yes | 161 (26.52) | (23.16 to 30.19) |
Smokeless tobacco users | ||
 No | 321 (52.88) | (48.89 to 56.84) |
 Yes | 286 (47.12) | (43.16 to 51.11) |
Physical activity (walk > 150 min per week) | ||
 No | 184 (30.31) | (26.78 to 34.10) |
 Yes | 423 (69.69) | (65.9 to 73.22) |
Tumor site | ||
 Oral | 67 (11.04) | (8.78 to 13.79) |
 Breast | 107 (17.63) | (14.79 to 20.87) |
 Lung | 66 (10.87) | (8.63 to 13.61) |
 Blood | 12 (1.98) | (1.12 to 3.45) |
 Pancreas | 13 (2.14) | (1.25 to 3.66) |
 Liver | 21 (3.46) | (2.26 to 5.25) |
 Cervix | 121 (19.93) | (16.94 to 23.31) |
 Brain | 12 (1.98) | (1.12 to 3.45) |
 Throat | 16 (2.64) | (1.62 to 4.26) |
 Other sites | 172 (28.34) | (24.89 to 32.06) |
Tumor stage | ||
 Stage-0 | 20 (3.29) | (2.13 to 5.06) |
 Stage-I | 254 (41.85) | (37.97 to 45.82) |
 Stage-II | 199 (32.78) | (29.16 to 36.63) |
 Stage-III | 102 (16.80) | (14.03 to 20.00) |
 Stage-IV | 32 (5.27) | (3.75 to 7.36) |
Ongoing treatment facility | ||
 Public facility | 533 (87.81) | (84.95 to 90.19) |
 Private facility | 74 (12.19) | (9.81 to 15.05) |